Q1 2021 Forte Biosciences Inc Earnings Call Transcript
Welcome to Forte Biosciences First Quarter 2021 Conference Call. My name is David, and I will be the operator for this call. On the call are Paul Wagner, Chairman and Chief Executive Officer of Forte Biosciences; Dan Burge, Forte's Chief Medical Officer; and Tony Riley, Forte's Chief Financial Officer.
Before I turn the call over to Paul and Tony to discuss the business and financial highlights of the first quarter, I would like to make a comment regarding forward-looking statements. Many of the statements made during the call today are forward-looking statements, including statements with respect to the company's cash position and the potential development time line of the company's product candidate. Actual results could differ materially from those contemplated by our forward-looking statements, and reported results should not be considered as an indication of future performance. Please look at our filings with the SEC for a discussion of the factors that could cause our results to differ materially. Additional information is also set forth in Forte's quarterly report on Form 10-Q for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
